COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Articles Not Curated -
Drug studies in animals
Last updated: 2024 Apr 18
Total hit(s): 810
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38594459
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection.
Sci Rep
2024 Apr 9
4.12
1
2
38438233
Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity.
Anal Chim Acta
2024 Apr 8
5.31
1
3
38588829
Throat spray formulated with virucidal Pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS CoV-2.
Eur J Pharm Biopharm
2024 Apr 6
1
4
38575586
The metabolic footprint of Vero E6 cells highlights the key metabolic routes associated with SARS-CoV-2 infection and response to drug combinations.
Sci Rep
2024 Apr 4
4.12
1
5
38608595
In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.
Phytomedicine
2024 Apr 4
7.2
1
6
38597182
Enteric coronavirus nsp2 is a virulence determinant that recruits NBR1 for autophagic targeting of TBK1 to diminish the innate immune response.
Autophagy
2024 Apr 16
10.79
1
7
38607375
Genotoxicity and safety pharmacology of the rVSVInd(GML)-mspSGtc vaccine against SARS-CoV-2 in Sprague-Dawley rats and Beagle dogs.
Arch Toxicol
2024 Apr 12
5.66
1
8
38607273
The mouse to man conundrum: Revisiting an old lung injury model to study repurposed drugs for COVID-19 treatment.
Exp Physiol
2024 Apr 12
4.3
1
9
38573021
Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin-converting enzyme 2.
Pharmacol Res Perspect
2024 Apr
3.3
1
10
38479071
Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
Virology
2024 Mar 7
2.819
1
11
38547259
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model.
Science
2024 Mar 29
20.57
1
12
38554446
Strategic development of a self-adjuvanting SARS-CoV-2 RBD vaccine: From adjuvant screening to enhanced immunogenicity with a modified TLR7 agonist.
Int Immunopharmacol
2024 Mar 29
3.38
1
13
38543849
A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against beta-Coronaviruses in a Murine Model.
Viruses
2024 Mar 21
3.76
1
14
37544514
Niclosamide: A career builder PART I: (Almost) Everything You Wanted To Know About Niclosamide But Were Too Afraid To Ask PART II: Nanomedicines? A Carrier-Free Nanomedicine for Cancer and a Simple Buffered Solution to Prevent COVID19 and Other Respiratory Infections: They Just Need Testing Invited Manuscript: J Controlled Release VSI in Honor of Prof. Park.
J Control Release
2024 Mar 21
15.5
1
15
38486021
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.
Nat Immunol
2024 Mar 14
18.5
1
16
38472181
Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2.
Nat Commun
2024 Mar 12
11.8
1
17
38466126
In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS-COV-2 Main Protease Inhibitors.
Chem Biodivers
2024 Mar 11
1
18
38471595
Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs.
Eur J Pharm Sci
2024 Mar 10
3.66
1
19
38425270
A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.
J Med Virol
2024 Mar
2.07
1
20
38445768
A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine.
J Med Virol
2024 Mar
2.07
1
21
38527094
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.
PLoS Pathog
2024 Mar
6.18
1
22
38340419
Fourth dose of microneedle array patch of SARS-CoV-2 S1 protein subunit vaccine elicits robust long-lasting humoral responses in mice.
Int Immunopharmacol
2024 Feb 9
3.38
1
23
38341953
A validated LC-MS/MS method for determination of six Anti-SARS-CoV-2 drugs in plasma and its application for a pharmacokinetic study in rats.
J Chromatogr B Analyt Technol Biomed Life Sci
2024 Feb 7
1
24
38320990
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination.
Cell Discov
2024 Feb 6
4.65
1
25
38340650
A tale of lockdown policies on the transmission of COVID-19 within and between Chinese cities: A study based on heterogeneous treatment effect.
Econ Hum Biol
2024 Feb 5
3.4
1